Accessibility Menu
Outset Medical logo

Outset Medical(NASDAQ) OM

Market Cap$87.50MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-99%
5 Year-99%
1 Year-74%
1 Month+3%
$4.61
-2.33%
-0.11Today
Outset Medical last closing stock price
MetricPriceDate
Last closeUSD 4.722026-07-28
Outset Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+14.56%USD 4.122026-07-21
1 month+3.06%USD 4.582026-06-26
3 month+12.92%USD 4.182026-04-29
Year to date+27.22%USD 3.712025-12-31
1 year-73.84%USD 18.042025-07-28
3 year-98.4%USD 294.152023-07-28
5 year-99.25%USD 626.552021-07-29
Since inception-99.48%USD 910.202020-09-15

Outset Medical Financials at a Glance

Market Cap

$87.50MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$117.59M

Net Income (TTM)

-$74.85M

EPS (TTM)

-$4.18

P/E Ratio

-1.13

Dividend

$0.00

Beta (Volatility)

1.30 (Average)

Price

$4.61

Volume

61,787.147

Open

$4.68

Previous Close

$4.66

Daily Range

$4.55 - $4.78

52-Week Range

$3.00 - $17.89

Estimated Earnings Date

Aug 6, 2026

OM: Motley Fool Moneyball Superscore

46

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Outset Medical

Outset Medical makes dialysis machines for people with kidney failure. Its main product, Tablo, lets hospitals and homes do dialysis using only tap water and electricity. This helps patients get treatment in more places with less setup.

Dialysis, Delivered: Products and Services

  • Tablo Console (26% of 2024 revenue): Compact dialysis machine for hospitals, clinics, and home use; needs only tap water and power.
  • Consumables (45%): Single-use cartridges, electrolyte concentrates, and tubing needed for each dialysis session.
  • Service and Other (29%): Maintenance, repair, training, and cloud connectivity for Tablo devices.
  • Tablo Data Ecosystem: Software tools for remote monitoring, patient records, and analytics for providers and patients.
  • TabloCart with Prefiltration: Accessory cart for storage and water prefiltration, FDA-cleared in 2024.

Plot Twists: Growth and Expansion

  • Launched Tablo Hemodialysis System for hospitals following FDA clearance prior to 2020; expanded to home use in 2020.
  • Resumed distribution of TabloCart with Prefiltration after FDA clearance in May 2024.
  • Invested in in-house manufacturing in Mexico and contract production in Thailand.
  • Launched pilot clinical and administrative services program for providers in 2022.
  • Raised $168.8 million in Series A Preferred Stock in January 2025.

What Makes Outset Medical Stand Out

Outset Medical focuses on a single, integrated dialysis platform for all care settings. Its machines require minimal infrastructure, making them accessible for hospitals and homes. The company’s cloud-based software supports remote monitoring and data-driven care.

Five Things You Need to Know

  • 2024 revenue was $113.7 million, down 13% from 2023.
  • Gross margin improved to 33.9% in 2024, up from 22.2% in 2023.
  • Operating loss was $113.4 million in 2024, improving 33% from 2023.
  • Cash and investments totaled $162.0 million at year-end 2024.

Bottom Line

Outset Medical has shifted from hardware sales to recurring revenue from consumables and services. The company continues to adapt its business model and operations to address industry and financial challenges.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Employees

310

CEO

Leslie L. Trigg, MBA

Headquarters

San Jose, CA 95134, US

OM Financials

Key Financial Metrics (TTM)

Gross Margin

40.64%

Operating Margin

-57.17%

Net Income Margin

-63.65%

Return on Equity

-55.88%

Return on Capital

-29.24%

Return on Assets

-30.00%

Earnings Yield

-88.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$87.50MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

18.54M

Volume

61.79K

Avg. Volume

224.08K

Financials (TTM)

Gross Profit

$47.78M

Operating Income

-$67.23M

EBITDA

-$57.11M

Operating Cash Flow

-$33.51M

Capital Expenditure

-$740.00K

Free Cash Flow

-$34.25M

Cash & ST Invst.

$156.71M

Total Debt

$101.61M

Outset Medical Performance Analysis

Outset Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 115,375,00012.4%
20232023-12-31USD 130,376,00013.0%
20242024-12-31USD 113,689,000-12.8%
20252025-12-31USD 119,476,0005.1%
Outset Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-305.6%
Q32025-09-30-6.3%
Q42025-12-31-1.9%
Q12026-03-31-3.5%
Outset Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -50.7516.9%
20232023-12-31USD -52.273.0%
20242024-12-31USD -36.95-29.3%
20252025-12-31USD -5.37-85.5%
Outset Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3086.0%
Q32025-09-303.8%
Q42025-12-31-9.0%
Q12026-03-315.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$27.86M

-6.3%

Gross Profit

$12.10M

+9.3%

Gross Margin

43.41%

N/A

Market Cap

$87.50MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$282.24K

N/A

Employees

310

N/A

Net Income

-$18.98M

+26.4%

EBITDA

-$14.60M

+3.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$156.71M

-17.1%

Total Debt

$101.61M

+3.5%

Accounts Receivable

$25.32M

-31.4%

Inventory

$49.65M

-11.0%

Long Term Debt

$99.79M

+3.6%

Short Term Debt

$1.82M

-1.7%

Return on Assets

-30.00%

N/A

Return on Invested Capital

-31.73%

N/A

Free Cash Flow

-$12.91M

+49.9%

Operating Cash Flow

-$12.84M

+50.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HSDTSolana Company
$1.65-2.37%
NNOXNano-X Imaging Ltd.
$0.88-0.05%
SNWVSANUWAVE Health Inc.
$6.38+0.31%
QTRXQuanterix Corporation
$3.38-3.15%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$8.41-0.06%
TAT&T
$23.94-0.03%
SMRNuScale Power
$7.59-0.08%
ORCLOracle
$117.74-0.02%

Questions About OM

What is the current price of Outset Medical?

Outset Medical is trading at $4.66 per share.

What is the 52-week range for Outset Medical?

Over the past 52 weeks, Outset Medical has traded between $3.00 and $17.89.

How much debt does Outset Medical have?

As of the most recent reporting period, Outset Medical reported total debt of $101.61M.

How much cash does Outset Medical have on hand?

Outset Medical reported $30.56M in cash and cash equivalents in its most recent financial results.

What is Outset Medical’s dividend yield?

Outset Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.